|
CTBS expression based on
|
| Comparison | Statistical significance |
| Normal-vs-Primary | 2.36019999999559E-05 |
|
Note
Cancer stage information is not available for 2 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Stage1 |
1.72264999999117E-05 |
| Normal-vs-Stage2 |
2.487600E-01 |
| Normal-vs-Stage3 |
3.478900E-03 |
| Normal-vs-Stage4 |
6.535900E-03 |
| Stage1-vs-Stage2 |
1.172960E-01 |
| Stage1-vs-Stage3 |
3.709200E-01 |
| Stage1-vs-Stage4 |
6.720800E-01 |
| Stage2-vs-Stage3 |
3.892800E-01 |
| Stage2-vs-Stage4 |
3.559200E-01 |
| Stage3-vs-Stage4 |
8.037400E-01 |
|
|
Note
Patient race information is not available for 92 samples and one samples from American Indians not included in the above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Caucasian |
2.420800E-04 |
| Normal-vs-AfricanAmerican |
3.955400E-04 |
| Normal-vs-Asian |
2.119300E-03 |
| Caucasian-vs-AfricanAmerican |
1.782020E-02 |
| Caucasian-vs-Asian |
3.489000E-01 |
| AfricanAmerican-vs-Asian |
1.697570E-01 |
|
|
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Male |
3.936300E-03 |
| Normal-vs-Female |
1.91897999999302E-05 |
| Male-vs-Female |
3.637800E-01 |
|
|
Note
Seventeen samples from patient below 21 years not considered in above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Age(21-40Yrs) |
5.90609999999714E-05 |
| Normal-vs-Age(41-60Yrs) |
2.356100E-04 |
| Normal-vs-Age(61-80Yrs) |
1.774160E-02 |
| Normal-vs-Age(81-100Yrs) |
9.824000E-01 |
| Age(21-40Yrs)-vs-Age(41-60Yrs) |
5.863800E-01 |
| Age(21-40Yrs)-vs-Age(61-80Yrs) |
2.520200E-01 |
| Age(21-40Yrs)-vs-Age(81-100Yrs) |
1.538000E-01 |
| Age(41-60Yrs)-vs-Age(61-80Yrs) |
4.638200E-01 |
| Age(41-60Yrs)-vs-Age(81-100Yrs) |
1.985390E-01 |
| Age(61-80Yrs)-vs-Age(81-100Yrs) |
3.469600E-01 |
|
|
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Classical-VS-Tall |
4.517600E-01 |
| Classical-VS-Follicular |
2.377300E-04 |
| Classical-VS-Other |
1.086580E-01 |
| Classical-VS-Normal |
1.74640000016879E-07 |
| Tall-VS-Follicular |
8.169900E-02 |
| Tall-VS-Other |
1.787400E-01 |
| Tall-VS-Normal |
6.421300E-03 |
| Follicular-VS-Other |
7.368000E-01 |
| Follicular-VS-Normal |
3.696800E-01 |
| Other-VS-Normal |
9.946600E-01 |
|
|
Note
Cancer in nearby lymph nodes cannot be measured (NX) in 50 samples.
| pathologic_N descriptions |
| N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
| N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-N0 |
1.194120E-02 |
| Normal-vs-N1 |
9.724200E-03 |
| N0-vs-N1 |
3.621800E-01 |
|
|
